ORBITA: Learning the Right Lessons From a Sham-controlled Trial of Angioplasty

    loading  Checking for direct PDF access through Ovid

Abstract

In this sham-controlled trial of 200 patients with single-vessel coronary artery disease and stable angina, percutaneous coronary intervention did not increase exercise time significantly compared to a placebo procedure.

Related Topics

    loading  Loading Related Articles